BTK Inhibitors in CLL: Striking a Balance Between Effectiveness and Heart Health
Array
Activity Info
This interactive microlearning case series is designed for hematology/oncology fellows and focuses on the fundamentals of cardio-oncology and the use of BTK inhibitors in CLL treatment. Through short, focused modules, learners will engage with real-world patient scenarios to support clinical decision-making.